AGM/EGMJun 4, 2026, 04:42 PM
Medicus Pharma Shareholders Approve Auditor, Elect Directors, & Share Consolidation
AI Summary
Medicus Pharma Ltd. held its 2026 Annual General and Special Meeting of Shareholders on June 3, 2026. Shareholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the 2026 fiscal year. All nine directors nominated by the Board were elected to serve one-year terms. Additionally, shareholders approved a special resolution authorizing the Board to effect a common share consolidation at a ratio up to 50-to-1, if deemed necessary or desirable.
Key Highlights
- Shareholders ratified KPMG LLP as the independent auditor with 28,308,860 votes For.
- All nine nominated directors were elected to serve one-year terms.
- William L. Ashton received 15,181,189 votes For election as director.
- Dr. Raza Bokhari received 15,068,465 votes For election as director.
- Shareholders approved a special resolution for a potential common share consolidation.
- The consolidation ratio can be up to 50 pre-consolidation shares for every one post-consolidation share.
- The share consolidation proposal received 26,729,776 votes For and 2,335,461 votes Against.
Price Impact
More from MDCX